Rehmann Capital Advisory Group’s Exact Sciences EXAS Stock Holding History

Rehmann Capital Advisory Group’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,860	Closed	-$232K	–	552
2021 Q2	$232K	Buy	1,860 +15	+0.8%	+$1.79K	0.02%	494
2021 Q1	$243K	Sell	1,845 -1	-0.1%	-$137	0.02%	461
2020 Q4	$245K	Buy	+1,846	New	+$223K	0.03%	424
2019 Q3	–	Sell	-2,810	Closed	-$332K	–	1797
2019 Q2	$332K	Buy	2,810 +1,549	+123%	+$156K	0.04%	327
2019 Q1	$109K	Hold	1,261	–	–	0.01%	565
2018 Q4	$79.6K	Sell	1,261 -7	-0.6%	-$480	0.01%	461
2018 Q3	$100K	Hold	1,268	–	–	0.01%	587
2018 Q2	$75.8K	Buy	1,268 +17	+1%	+$915	0.01%	646
2018 Q1	$50K	Buy	+1,251	New	+$61K	0.01%	764

Other funds holding EXAS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Rehmann Capital Advisory Group's EXAS Position: Q3 2021 in Review

Rehmann Capital Advisory Group sold out of Exact Sciences (EXAS) in Q3 2021, closing a stake of 1,860 shares — an estimated $232K sold.

Rehmann Capital Advisory Group first reported a position in EXAS in Q1 2018 and held it in 9 quarters. The position peaked at $332K in Q2 2019. 602 funds tracked by Wall St. Rank hold EXAS as of Q3 2021.

Rehmann Capital Advisory Group reported no remaining Exact Sciences position as of Q3 2021 after selling out during the quarter.
Rehmann Capital Advisory Group sold 1,860 Exact Sciences shares in Q3 2021, an estimated $232K.
Rehmann Capital Advisory Group first reported a position in Exact Sciences in Q1 2018 and held it in 9 quarters.
Rehmann Capital Advisory Group's Exact Sciences position peaked at $332K in Q2 2019.
602 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2021.

Based on Rehmann Capital Advisory Group's 13F filing for Q3 2021, filed 16 Nov 2021.